CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Syneos Health Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Syneos Health Inc
1030 Sync Street
Phone: (919) 876-9300p:919 876-9300 MORRISVILLE, NC  27560  United States Fax: (919) 876-9360f:919 876-9360
This company ceased filing statements with the SEC on 10/10/2023.
On 9/28/2023, the Company was acquired by a Consortium composed of Elliott Investment Management L.P., Patient Square Capital and Veritas Capital.
This company is no longer actively traded on any major stock exchange.
Business Summary
Syneos Health, Inc. is a biopharmaceutical solutions company that utilizes outsourced clinical drug development and commercialization services. The Company operates through two business segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. The Clinical Solutions segment offers individual services including product development, project management, protocol development, investigational site recruitment, and clinical monitoring. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions (public relations, advertising, and medical communications), and consulting services. The Company’s customers include small, mid-sized, and large companies in the biopharmaceutical, biotechnology, and medical device industries.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-YesYes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202312/31/2022YesYes-YesYes

Industries
SIC Code Description
8731 Commercial physical and biological research
8742 Management consulting services

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Independent Chairman of the Board John M.Dineen 60 12/10/2018 12/10/2018
Chief Executive Officer, Director MichelleKeefe 56 4/29/2022 12/1/2017
Chief Financial Officer Michael J.Bonello 53 7/1/2023 7/1/2023
8 additional Officers and Directors records available in full report.

Business Names
Business Name
Boco Digital Media, LLC
Caerus Marketing Group, LLC
Campbell Alliance Group, Inc.
131 additional Business Names available in full report.

General Information
Number of Employees: 28,768 (As of 12/31/2022)
Outstanding Shares: 103,719,179 (As of 7/31/2023)
Shareholders: 20
Stock Exchange: NASD
Federal Tax Id: 273403111
Fax Number: (919) 876-9360


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 17, 2024